Navigation Links
Seattle Reproductive Medicine Study Investigates Newly Formulated Medications for Luteal Support in IVF
Date:1/14/2009

SEATTLE, Jan. 14 /PRNewswire/ -- Patients undergoing in vitro fertilization self-administer daily injections of progesterone from two to eight weeks after the egg retrieval procedure. The outcome of a new study of an investigational formulation of progesterone could replace these painful intramuscular injections of progesterone in oil with less painful subcutaneous injections.

Seattle Reproductive Medicine (SRM), along with eight other large fertility centers across the country, has been selected to participate in a study designed to compare the safety and effectiveness of an investigational aqueous formulation of progesterone that will be compared to a form of progesterone administered intra-vaginally.

"For years patients have complained about these injections. One shot may be tolerable, but many weeks of daily injections is a long time for this degree of discomfort," says Dr. Michael Soules, MD, SRM's managing partner. Dr. Soules is the principle investigator for the U.S. arm of this study. He adds, "Being a large practice affords us the opportunity to make these types of studies available to our patients. These studies help patients offset the cost of their treatment."

Progesterone supplementation is routinely given after egg recovery for two weeks or longer to assist embryo implantation and support of the uterine lining. Progesterone in oil injected intramuscularly is the usual means of administration. These self-administered injections can be quite painful. The drug being tested is a new formulation of an existing approved medication. If outcome, tolerability and safety are the same or better with the investigational formulation of progesterone then patients would no longer be subjected to these drugs.

Study participants must be in an IVF cycle and will receive study related medications valued near $300 at no cost and a $1500 payment for participation. Enrollment in the
'/>"/>

SOURCE Seattle Reproductive Medicine
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. A Place for Mom COO Makes Seattles 40 Under 40 List
2. Seattle Surgeon Named 2007 Veterinarian of the Year
3. Math battling cancer, deciding lifes challenges lead list as INFORMS meet in Seattle
4. WELLESSE ALL DAY ENERGY(TM) - Sponsors of the UW Medical Center 2007 Seattle Marathon
5. MultiCare Joins Seattle Cancer Care Alliance Network
6. Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment
7. Upscale Seattle-Based Skincare Clinic Expands Into California With Unique Custom Tailored Skincare Approach
8. Seattle-Based Law Firm Williams Kastner Receives Significant Defense Verdict in Trade Secret Business Litigation Case
9. Seattle-Based Marsha Rivkin Center for Ovarian Cancer Research Appoints Nancy Sclater, Executive Director
10. Compressus Announces Seattle Radiologists Interoperability Implementation
11. Seattle Laces Up To Beat the Bridge and Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... a driving force behind many chronic diseases, especially ... inflammation caused by conditions such as viral hepatitis ... options. Now, scientists at Virginia Commonwealth University Massey ... in preclinical studies that blocking the expression of ... halts the development and progression of liver cancer ...
(Date:9/23/2014)... Wellesley, Mass., September 23, 2014 – BCC Research ( ... Joint Reconstruction and Replacement: Materials, Technologies, and Global Markets ... is expected to increase to nearly $16.2 billion by ... 4.2% from 2013 through 2018. The U.S. occupies the ... CAGR of 5.1%. , Revision and partial joint replacement ...
(Date:9/23/2014)... eCaring, a leading health care quality ... contract to provide its unique Web-based home health care ... New York City’s largest not-for-profit health plans. Elderplan, an ... to help enhance the care of its Medicare, Medicaid ... Elderplan has been at the forefront of offering New ...
(Date:9/23/2014)... NY (PRWEB) September 23, 2014 ... revenue for the Fruit and Vegetable Markets ... consumption and fruit prices benefited operators over the ... industry follow unique preference and demographic trends, including ... US population. While per capita fruit and vegetable ...
(Date:9/23/2014)... the results of their cancer research at ESMO ... Joint Symposium: ESMO-ASCO: The Evolution of the ... AM - 12:30 PM, Room: Granada, Abstract 121IN: ... new forms of cancer clinical research? The example ... Paper session: Melanoma and other skin tumors , ...
Breaking Medicine News(10 mins):Health News:Study uncovers genetic driver of inflammation, uses it to prevent and treat liver cancer 2Health News:Global Market for Joint Reconstruction and Replacement to reach $16.2 Billion in 2018; The U.S. Market Moving at 5.1% CAGR 2Health News:Global Market for Joint Reconstruction and Replacement to reach $16.2 Billion in 2018; The U.S. Market Moving at 5.1% CAGR 3Health News:eCaring Signs Care Management Contract with Elderplan, Inc. 2Health News:Fruit & Vegetable Markets in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Fruit & Vegetable Markets in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:EORTC presentations at ESMO 2014 Congress 2Health News:EORTC presentations at ESMO 2014 Congress 3
... organizations that address health care ... access and priorities in a four-state region, PORTLAND, ... insurer in the Northwest/ Intermountain region, announced today the,launch ... in,the United States. The Regence Foundation estimates it will ...
... Northwest Hospital &,Medical Center announced today that it will ... 2008 KING 5 Healthy Living Expo, from 10 a.m.,- ... 20, at the Qwest Field,Exhibition Center West Hall., ... expected attendance,of more than 44,000 people. Admission is free., ...
... April 14 U.S. Environmental,Protection Agency Region 5 ... alleged clean-air violations at the company,s coal preparation,plant ... Beallsville, Ohio., The agreement, which includes a ... comply with testing, notification and,reporting requirements at the ...
... can cause an aggressive,form of acute lymphoblastic leukemia ... April 14 Researchers at St.,Jude Children,s Research ... mutations work together to initiate most cases of ... (ALL)., These defects, known as "cooperating oncogenic ...
... CCA Industries, Inc.,(Amex: CAW ) announced today ... share fully diluted of $0.05 for the first,quarter ended ... year,were $13,975,385, and net income was $472,753, with fully ... net income has always been the lowest quarter,because the ...
... petinsurance.com, BREA, Calif., April 14 Veterinary ... of pet health insurance, has,designated the last Sunday ... as National,Pet Parent,s Day, slating the nation,s first ... of a spring season set aside for,celebrating parents ...
Cached Medicine News:Health News:Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate 2Health News:Northwest Hospital & Medical Center Hosts Health & Wellness Pavilion At Second Annual King 5 Healthy Living Expo 2Health News:St. Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 2Health News:St. Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 3Health News:CCA Industries, Inc. Announces First Quarter Results 2Health News:Veterinary Pet Insurance Launches National Pet Parent's Day 2
(Date:9/23/2014)... BERGEN, Norway , September 23, 2014 /PRNewswire/ ... "Company"), an oncology biopharmaceutical company, today announces it ... million) Seeding Drug Discovery Award from the UK,s ... against BGB002, its proprietary, novel cancer target. ... are to identify and fund especially promising, innovative ...
(Date:9/23/2014)... , Sept. 23, 2014  As physicians ... to digital communication channels to learn about new ... finding – from a new report by global ... – shows that communicating via a customized mix ... provides the best opportunity to engage with physicians. ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
Breaking Medicine Technology:BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 2BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 2As sales reps see doors close for in-person visits with physicians, digital doors open communication 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 4As sales reps see doors close for in-person visits with physicians, digital doors open communication 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7
... Harco Metal Products (Harco), an industry leader in tube fabrication, systems ... manufacture MediGLIDER™ products for ConMediSys. , ... ConMediSys, the developer of safety products for health ... cost associated with staff injuries caused by physically lifting and moving ...
... 23 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... 26, 2010 , at 8:00 a.m. Eastern Time ( 5:00 ... , , ... live webcast of the presentation on the company,s website at: http://www.onyx-pharm.com/view.cfm/32/Event-Calendar ...
Cached Medicine Technology:Harco Partners With ConMediSys to Deliver Patient Safety and Equipment Integrity 2Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide a Clinical Update on Carfilzomib 2
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, low viscosity bone cement for syringe use with an average setting time of approx. 7-9 Min., 41.6g of powder and 16.4g of liquid....
... Featuring new technology, such as a recessed ... and lens housings, this arthroscope has superior ... by EO, Steris and steam autoclaving or ... Light post/adapters to fit ACMI, Wolf, Dyonics ...
... Passport II delivery device is the second ... C11UB. Its simple-to-use syringe technology allows one-handed ... small incision. The blue colored plunger allows ... protect the haptics during insertion. The modified ...
Medicine Products: